Comparing circulating mutational load of KRAS G12D and G12S in distant metastasized CRC patients in our study to the work by Thierry et al. [6] revealed a 5.2-fold and 48.7-fold decrease in median ctDNA yield and allelic frequency, respectively. Here, KRAS is linked to colorectal carcinoma.